Usefulness of famotidine in functional dyspepsia patient treatment: Comparison among prokinetic, acid suppression and antianxiety therapies

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 21, Issue 2, 2005, Pages 32-36

  Seno, H ^a   Nakase, H ^a   Chiba, T ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT; FAMOTIDINE; MOSAPRIDE CITRATE; PROKINETIC AGENT; STOMACH SECRETION INHIBITOR; TANDOSPIRONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSPEPSIA; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH ACID SECRETION; SYMPTOMATOLOGY; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

EID: 20444375508     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02471.x     Document Type: Article

References (19)

1. Klauser AG, Voderholzer WA, Knesewitsch PA, Schindlbeck NE, Muller-Lissner SA. What is behind dyspepsia? Dig Dis Sci 1993; 38: 147-54.
2. Stanghellini V, Tosetti C, Paternico A, et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 1996; 110: 1036-42.
3. Finny JS, Kinnersley N, Hughes M, O'Bryan-Tear CG, Lothian J. Meta-analysis of antisecretory and gastrokinetic compounds in functional dyspepsia. J Clin Gastroenterol 1998; 26: 312-20.
4. Allescher H-D, Boeckenhoff A, Knapp G, Wienbeck M, Hartung J. Treatment of non-ulcer dyspepsia: a meta-analysis of placebo-controlled prospective studies. Scand J Gastroenterol 2001; 36: 934-41.
5. Halter F, Miazza B, Brignoli R. Cisapride or cimetidine in the treatment of functional dyspepsia. Results of a double-blind, randomized, Swiaa Multicentre Study. Scand J Gastroenterol 1994; 29: 618-23.
6. Quartero AO, Numans ME, de Melker RA, Hoes AW, de Wit NJ. Dyspepsia in primary care: acid suppression as effective as prokinetic therapy, A randomized clinical trial. Scand J Gastroenterol 2001; 36: 942-7.
7. Clouse RE. Antidepressants for functional gastrointestinal syndromes. Dig Dis Sci 1994; 39: 2352-63,
8. Quartero AO, Post MW, Numans ME, de Melker RA, de Wit NJ. What makes the dyspeptic patient feel ill? A cross sectional survey of functional health status, Helicobacter pylori infection, and psychological distress in dyspeptic patients in general practice. Gut 1999; 45: 15-9.
9. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GNJ. Functional gastroduodenal disorders. Gut 1999; 45: 37-42.
10. Mearin F, de Ribot X, Balboa A, et al Does Helicobacter pylori infection increase gastric sensitivity in functional dyspepsia? Gut 1995; 37: 47-51.
11. Veldhuyzen van Zanten SJ, Jones MJ, Verlinden M, Talley NJ, Efficacy of cisapride and domperidone in functional dyspepsia: a meta-analysis. Am J Gastroenterol 2001; 96: 689-96.
12. Samsom M, Verhagen MA, van Berge Henegouwen GP, Smout AJPM. Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in dyspeptic patients. Gastroenterology 1999; 116: 515-20.
13. Lee K, Demarchi B, Demedts I, Sifrim D, Raeymaekers P, Tack J. A pilot study on duodenal acid exposure and its relationship to symptoms in functional dyspepsia with prominent nausea. Am J Gastroenterol 2004; 99: 1765-73.
14. Schwarz MP, Samsom M, van Berge Henegouwen GP, Smout AJPM. Effect of inhibition of gastric acid secretion on antropyloroduodenal motor activity and duodenal acid hypersensitivity in functional dyspepsia. Aliment Pharmacol Ther 2001; 15: 1921-8.
15. Talley NJ, Meineche-Schmidt V, Pare P, et al. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther 1998; 12: 1055-65.
16. Blum AL, Arnold R, Stolte M, Fischer M, Koelz HK. Short course acid suppressive treatment for patients with functional dyspepsia: results depend on Helicobacter pylori status. The Frosch Study Group. Gut 2000; 47: 473-80.
17. Mearin F, Balboa A, Zarate N, Cucala M, Malagelada J-R. Placebo in functional dyspepsia: symptomatic, gastrointestinal motor, and gastric sensorial responses. Am J Gastroenterol 1999; 94: 116-25.
18. Soo S, Moayyedi P, Deeks J, Delaney B, Lewis M, Forman D. Psychological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev 2001; 4: CD002301.
19. Tack J, Broeckaert D, Coulie B, Fischler B, Janssens J. Influence of the selective serotonin re-uptake inhibitor, paroxetine, on gastric sensorimotor function in man. Aliment Pharmacol Ther 2003; 17: 603-8.